DOI QR코드

DOI QR Code

Should We Remove the Retrievable Cook Celect Inferior Vena Cava Filter? Eight Years of Experience at a Single Center

  • Son, Joohyung (Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital) ;
  • Bae, Miju (Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital) ;
  • Chung, Sung Woon (Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital) ;
  • Lee, Chung Won (Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital) ;
  • Huh, Up (Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital) ;
  • Song, Seunghwan (Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital)
  • Received : 2017.05.12
  • Accepted : 2017.08.17
  • Published : 2017.12.05

Abstract

Background: The inferior vena cava filter (IVCF) is very effective for preventing pulmonary embolism in patients who cannot undergo anticoagulation therapy. However, if a filter is placed in the body permanently, it may lead to other complications. Methods: A retrospective study was performed of 159 patients who underwent retrievable Cook Celect IVCF implantation between January 2007 and April 2015 at a single center. Baseline characteristics, indications, and complications caused by the filter were investigated. Results: The most common underlying disease of patients receiving the filter was cancer (24.3%). Venous thrombolysis or thrombectomy was the most common indication for IVCF insertion in this study (47.2%). The most common complication was inferior vena cava penetration, the risk of which increased the longer the filter remained in the body (p=0.032, Exp(B)=1.004). Conclusion: If the patient is able to retry anticoagulation therapy and the filter is no longer needed, the filter should be removed, even if a long time has elapsed since implantation. If the filter cannot be removed, it is recommended that follow-up computed tomography be performed regularly to monitor the progress of venous thromboembolisms as well as any filter-related complications.

Keywords

References

  1. White RH. The epidemiology of venous thromboembolism. Circulation 2003;107(23 Suppl 1):I4-8.
  2. Passman MA. Vena cava interruption and pulmonary embolism. In: Rutherford RB, Cronenwett JL, Johnston KW, editors. Rutherford's vascular surgery. 8th ed. Philadelphia (PA): Elsevier Saunders; 2014. p. 811-32.
  3. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001;86:452-63. https://doi.org/10.1055/s-0037-1616243
  4. Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 1991;302:709-11. https://doi.org/10.1136/bmj.302.6778.709
  5. Jang MJ, Bang SM, Oh D. Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost 2011;9:85-91. https://doi.org/10.1111/j.1538-7836.2010.04108.x
  6. Oh JC, Trerotola SO, Dagli M, et al. Removal of retrievable inferior vena cava filters with computed tomography findings indicating tenting or penetration of the inferior vena cava wall. J Vasc Interv Radiol 2011;22:70-4. https://doi.org/10.1016/j.jvir.2010.09.021
  7. Lee JK, So YH, Choi YH, et al. Clinical course and predictive factors for complication of inferior vena cava filters. Thromb Res 2014;133:538-43. https://doi.org/10.1016/j.thromres.2014.01.004
  8. Hoffer EK, Mueller RJ, Luciano MR, Lee NN, Michaels AT, Gemery JM. Safety and efficacy of the Gunther Tulip retrievable vena cava filter: midterm outcomes. Cardiovasc Intervent Radiol 2013;36:998-1005. https://doi.org/10.1007/s00270-012-0517-7
  9. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000;160:809-15. https://doi.org/10.1001/archinte.160.6.809
  10. Bae MJ, Chung SW, Lee CW, Kim S, Song S. Duodenal perforation caused by an inferior vena cava filter. Korean J Thorac Cardiovasc Surg 2012;45:69-71. https://doi.org/10.5090/kjtcs.2012.45.1.69
  11. White RH, Geraghty EM, Brunson A, et al. High variation between hospitals in vena cava filter use for venous thromboembolism. JAMA Intern Med 2013;173:506-12. https://doi.org/10.1001/jamainternmed.2013.2352
  12. PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 2005;112:416-22. https://doi.org/10.1161/CIRCULATIONAHA.104.512834